Biology subjects

Alzheimer's Disease Neuroimaging Initiative,

Publications and source records attributed to Alzheimer's Disease Neuroimaging Initiative,.

8 recordsLinked to original sources

bioRxiv2018

GenEpi: Gene-based Epistasis Discovery Using Machine Learning

Genome-wide association studies (GWAS) provide a powerful means to identify associations between genetic variants and phenotypes. However, GWAS techniques for detecting epistasis, the interactions between genetic variants associated with phenotypes, are still limited. We believe that developing an efficient and effective GWAS method to detect epistasis will be a key for discovering sophisticated pathogenesis, which is especially important for complex diseases such as Alzheimers disease (AD). In this regard, this study presents GenEpi, a computational package to uncover epistasis associated with phenotypes by the proposed machine learning approach. GenEpi identifies both within-gene and cross-gene epistasis through a two-stage modeling workflow. In both stages, GenEpi adopts two-element combinatorial encoding when producing features and constructs the prediction models by L1-regularized regression with stability selection. The simulated data showed that GenEpi outperforms other widely-used methods on detecting ground-truth epistasis. As real data is concerned, this study uses AD as an example to reveal the capability of GenEpi in finding disease-related variants and variant interactions that show both biological meanings and predictive power. Availability: GenEpi is an open-source python package and available free of charge only for non-commercial users. The package can be downloaded from https://github.com/Chester75321/GenEpi, and has also been published on The Python Package Index.

bioinformatics↗

bioRxiv2018

Quantification of Structural Brain Connectivityvia a Conductance Model

Connectomics has proved promising in quantifying and understanding the effects of development, aging and an array of diseases on the brain. In this work, we propose a new structural connectivity measure that allows us to incorporate direct brain connections as well as indirect ones that would not be otherwise accounted for by standard techniques and that may be key for the better understanding of function from structure. From our experiments on the Human Connectome Project dataset, we find that our measure of structural connectivity better correlates with functional connectivity than streamline tractography does, meaning that it provides new structural information related to function. Through additional experiments on the ADNI-2 dataset, we demonstrate the ability of this new measure to better discriminate different stages of Alzheimers disease. Our findings suggest that this measure is useful in the study of the normal brain function and structure, and for quantifying the effects of disease on brain structure.

neuroscience↗

bioRxiv2018

A signature of cognitive deficits and brain atrophy that is highly predictive of progression to Alzheimer’s dementia

Patients with mild cognitive impairment (MCI) are at risk of progressing to Alzheimers dementia, yet only a fraction of them do. We explore here whether a very high-risk MCI subgroup can be identified using cognitive assessments and structural neuroimaging. A multimodal signature of Alzheimers dementia was first extracted using machine learning tools in the ADNI1 sample, and was comprised of cognitive deficits across multiple domains as well as atrophy in temporal, parietal and occipital regions. We then validated the predictive value of this signature on two MCI cohorts. In ADNI1 (N=235), the presence of the signature predicted progression to dementia over three years with 80.4% positive predictive value, adjusted for a \"typical\" MCI baseline rate of 33% (95.6% specificity, 55.1% sensitivity). These results were replicated in ADNI2 (N=235), with 87.8% adjusted positive predictive value (96.7% specificity, 47.3% sensitivity). Our results demonstrate that, even for widely used markers, marked improvement in positive predictive value over the literature can be achieved by focusing on a subgroup of individuals with similar brain characteristics. The signature can be readily applied for the enrichment of clinical trials.

neuroscience↗

bioRxiv2018

Systematic differences between visually-relevant global and local image statistics of brain MRI and natural scenes

An important heuristic in developing image processing technologies is to mimic the computational strategies used by humans. Relevant to this, recent studies have shown that the human brains processing strategy is closely matched to the characteristics of natural scenes, both in terms of global and local image statistics. However, structural MRI images and natural scenes have fundamental differences: the former are two-dimensional sections through a volume, the latter are projections. MRI image formation is also radically different from natural image formation, involving acquisition in Fourier space, followed by several filtering and processing steps that all have the potential to alter image statistics. As a consequence, aspects of the human visual system that are finely-tuned to processing natural scenes may not be equally well-suited for MRI images, and identification of the differences between MRI images and natural scenes may lead to improved machine analysis of MRI.\n\nWith these considerations in mind, we analyzed spectra and local image statistics of MRI images in several databases including T1 and FLAIR sequence types and of simulated MRI images,[1]-[6] and compared this analysis to a parallel analysis of natural images[7] and visual sensitivity[7][8]. We found substantial differences between the statistical features of MRI images and natural images. Power spectra of MRI images had a steeper slope than that of natural images, indicating a lack of scale invariance. Independent of this, local image statistics of MRI and natural images differed: compared to natural images, MRI images had smaller variations in their local two-point statistics and larger variations in their local three-point statistics - to which the human visual system is relatively insensitive. Our findings were consistent across MRI databases and simulated MRI images, suggesting that they result from brain geometry at the scale of MRI resolution, rather than characteristics of specific imaging and reconstruction methods.

neuroscience↗

bioRxiv2017

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

The heterogeneity of neurodegenerative diseases is a key confound to disease understanding and treatment development, as study cohorts typically include multiple phenotypes on distinct disease trajectories. Here we present a new machine learning technique - Subtype and Stage Inference (SuStaIn) - able to uncover data-driven disease phenotypes with distinct temporal progression patterns, from widely available crosssectional patient studies. Results from imaging studies in two neurodegenerative diseases reveal new subgroups and their distinct trajectories of regional neurodegeneration. In genetic frontotemporal dementia, SuStaIn identifies genotypes from imaging alone, validating its ability to identify subtypes, and characterises within-group heterogeneity for the first time. In Alzheimers disease, SuStaIn uncovers three subtypes, uniquely revealing their temporal complexity. SuStaIn provides fine-grained patient stratification, which substantially enhances the ability to predict conversion between diagnostic categories over standard models that ignore subtype (p=7.18x10--4) or temporal stage (p=3.96x10-5). SuStaIn thus offers new promise for enabling disease subtype discovery and precision medicine.

neuroscience↗

bioRxiv2017

Subtypes of functional brain connectivity as early markers of neurodegeneration in Alzheimer’s disease

HighlightsO_LIReliable functional brain network subtypes accompany cognitive impairment in AD\nC_LIO_LISymptom-related subtypes exist in the default-mode, limbic and salience networks\nC_LIO_LIA limbic subtype is associated with a familial risk of AD in healthy older adults\nC_LIO_LILimbic subtypes also associate with beta amyloid deposition and ApoE4\nC_LI\n\nIn BriefWe found reliable subtypes of functional brain connectivity networks in older adults, associated with AD-related clinical symptoms in patients as well as several AD risk factors/biomarkers in asymptomatic individuals.\n\nSummaryThe heterogeneity of brain degeneration has not been investigated yet for functional brain network connectivity, a promising biomarker of Alzheimers disease. We coupled cluster analysis with resting-state functional magnetic resonance imaging to discover connectivity subtypes in healthy older adults and patients with cognitive disorders related to Alzheimers disease, noting associations between subtypes and cognitive symptoms in the default-mode, limbic and salience networks. In an independent asymptomatic cohort with a family history of Alzheimers dementia, the connectivity subtypes had good test-retest reliability across all tested networks. We found that a limbic subtype was overrepresented in these individuals, which was previously associated with symptoms. Other limbic subtypes showed associations with cerebrospinal fluid A{beta}1-42 levels and ApoE4 genotype. Our results demonstrate the existence of reliable subtypes of functional brain networks in older adults and support future investigations in limbic connectivity subtypes as early biomarkers of Alzheimers degeneration.

neuroscience↗

bioRxiv2017

Genome-wide Association Study Links APOEϵ4 and BACE1 Variants with Plasma Amyloid β Levels

INTRODUCTIONThere is increasing interest in plasma A{beta} as an endophenotype and biomarker of Alzheimers disease (AD). Identifying the genetic determinants of plasma A{beta} levels may elucidate important processes that determine plasma A{beta} measures. METHODSWe included 12,369 non-demented participants derived from eight population-based studies. Imputed genetic data and plasma A{beta}1-40, A{beta}1-42 levels and A{beta}1-42/A{beta}1-40 ratio were used to perform genome-wide association studies, gene-based and pathway analyses. Significant variants and genes were followed-up for the association with PET A{beta} deposition and AD risk. RESULTSSingle-variant analysis identified associations across APOE for A{beta}1-42 and A{beta}1-42/A{beta}1-40 ratio, and BACE1 for A{beta}1-40. Gene-based analysis of A{beta}1-40 additionally identified associations for APP, PSEN2, CCK and ZNF397. There was suggestive interaction between a BACE1 variant and APOE{varepsilon}4 on brain A{beta} deposition. DISCUSSIONIdentification of variants near/in known major A{beta}-processing genes strengthens the relevance of plasma-A{beta} levels both as an endophenotype and a biomarker of AD.

genetics↗

bioRxiv2016

Multivariate association between single-nucleotide polymorphisms in Alzgene linkage regions and structural changes in the brain: discovery, refinement and validation

Both genetic variants and brain region abnormalities are recognized to play a role in cognitive decline. We explore the association between singlenucleotide polymorphisms (SNPs) in linkage regions for Alzheimers disease and rates of decline in brain structure using data from the Alzheimers Disease Neuroimaging Initiative (ADNI).\n\nIn an initial discovery stage, we assessed the presence of linear association between the minor allele counts of 75,845 SNPs in the Alzgene linkage regions and predicted rates of change in structural MRI measurements for 56 brain regions using an RV test. In a second, refinement stage, we reduced the number of SNPs using a bootstrap-enhanced sparse canonical correlation analysis (SCCA) with a fixed tuning parameter. Each SNP was assigned an importance measure proportional to the number of times it was estimated to have a nonzero coefficient in repeated re-sampling from the ADNI-1 sample. We created refined lists of SNPs based on importance probabilities greater than 50% and 90%, respectively. In a third, validation stage, we assessed the multivariate association between these refined lists of SNPs and the rates of structural change in the independent ADNI-2 study dataset.\n\nThere was strong statistical evidence for linear association between the SNPs in the Alzgene linkage regions and the 56 imaging phenotypes in both the ADNI-1 and ADNI-2 samples (p < 0.0001). The bootstrap-enhanced SCCA identified 1,694 priority SNPs with importance probabilities > 50% and 22 SNPs with importance probabilities > 90%. The 1,694 prioritized SNPs in the ADNI-1 data were associated with imaging phenotypes in the ADNI-2 data (p = 0.0021).\n\nThis manuscript presents an analysis that addresses challenges in current imaging genetics studies such as biased sampling designs and highdimensional data with low-signal. Genes corresponding to priority SNPs having the highest contribution in the validation data have previously been implicated or hypothesized to be implicated in AD, including GCLC, IDE, and STAMBP1andFAS. We hypothesize that the effect sizes of the 1,694 SNPs in the priority set are likely small, but further investigation within this set may advance understanding of the missing heritability in late-onset Alzheimers disease. Multivariate analysis; Linkage regions; Imaging genetics; Endophenotypes; Inverse probability weighting; Variable importance probabilities

neuroscience↗